Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 2 subfamily B member 4 pseudogene (OR2B4P) is annotated as a non-functional member of the human olfactory receptor gene family. Olfactory receptors are typically G protein-coupled receptors (GPCRs) that mediate odor detection in the nose, but pseudogenes like OR2B4P do not encode functional receptor proteins in most humans[5][1]. While some olfactory receptor pseudogenes in other species (or occasionally in humans due to rare genetic variations) can occasionally retain or reacquire function, there is no experimental evidence that OR2B4P is functional or druggable in humans[5][2][3]. As a member of the largest mammalian gene family, OR2B4P represents an evolutionary remnant of olfactory receptor diversification, but it is not considered a therapeutic target and has no established biological or clinical significance.
None known. (No drug mechanism is described or predicted for this gene product.)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 2 subfamily B member 4 pseudogene (OR2B4P).